2,977
Participants
Start Date
May 15, 2023
Primary Completion Date
March 21, 2025
Study Completion Date
March 21, 2025
Neuraxial Analgesia
This randomized group will receive a neuraxial morphine injection (intrathecal morphine/hydromorphone).
Regional Block 1: Paravertebral
This randomized group will receive regional technique analgesia with sodium channel nerve blockade pharmacotherapy (ie nerve block)
Perphenazine
This randomized group will receive 8 mg of perphenazine orally preoperatively.
Aprepitant
This randomized group will receive 40 mg of aprepitant orally preoperatively.
Dimenhydrinate
This randomized group will receive 25 mg of dimenhydrinate orally preoperatively.
Ondansetron 4 MG
This randomized group will receive 4 mg of ondansetron orally.
Dexamethasone
This randomized group will receive 4-5 mg of dexamethasone intravenously.
Regional Block 2: QL1
This randomized group will receive regional technique analgesia with sodium channel nerve blockade pharmacotherapy (ie nerve block)
UPMC Magee-Womens Hospital, Pittsburgh
UPMC Presbyterian, Pittsburgh
UPMC Passavant, Pittsburgh
Collaborators (1)
Berry Consultants
OTHER
Jennifer Holder-Murray
OTHER